Evidence map›Paper›PMID 42179245›Full record

ArticleJournal of the American Heart Association2026

Early Postrranscatheter Aortic Valve Replacement Heart Failure Hospitalization and Outcomes in Older Patients.

Harun Kundi, Martin Leon, David J Cohen, Alexandra Popma, Yukari Kobayashi, Bjorn Redfors, Lauren S Ranard, Maria C Alu, Julia B Thompson, Jennifer von Stein and 5 more

Abstract read
In one paragraph

Article in Journal of the American Heart Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Harun KundiCardiovascular Research Foundation New York NY USA.ORCID 0000-0002-0303-9619
Martin LeonCardiovascular Research Foundation New York NY USA.ORCID 0000-0002-2002-7492
David J CohenCardiovascular Research Foundation New York NY USA.ORCID 0000-0001-9163-724X
Alexandra PopmaCardiovascular Research Foundation New York NY USA.ORCID 0009-0004-4701-6234
Yukari KobayashiCardiovascular Research Foundation New York NY USA.ORCID 0000-0002-8304-8194
Bjorn RedforsCardiovascular Research Foundation New York NY USA.ORCID 0000-0002-4155-4451
Lauren S RanardCardiovascular Research Foundation New York NY USA.
Maria C AluCardiovascular Research Foundation New York NY USA.ORCID 0000-0002-0430-3020
Julia B ThompsonCardiovascular Research Foundation New York NY USA.ORCID 0009-0005-5659-9168
Jennifer von SteinCardiovascular Research Foundation New York NY USA.ORCID 0009-0000-3871-164X
Philipp von SteinCardiovascular Research Foundation New York NY USA.ORCID 0000-0003-4548-3897
Guido AscioneCardiovascular Research Foundation New York NY USA.ORCID 0000-0002-7727-0573
Afek KodeshCardiovascular Research Foundation New York NY USA.ORCID 0000-0001-5932-1181
Juan F GranadaCardiovascular Research Foundation New York NY USA.ORCID 0000-0003-2399-8320
Jeffrey J PopmaCardiovascular Research Foundation New York NY USA.ORCID 0009-0007-6413-1455

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTranscatheter aortic valve replacement (TAVR) improves symptoms and survival in patients with severe aortic stenosis, yet the incidence and prognostic significance of early postprocedural heart failure (HF) hospitalization remain incompletely characterized. Our objective is to determine the incidence, clinical characteristics, prognostic implications, and predictors of early HF hospitalization after TAVR.

methodsUsing the Medicare Provider Analysis and Review database, we identified fee-for-service beneficiaries ≥65 years who underwent TAVR between January 1, 2017, and November 30, 2021. Early post-TAVR HF hospitalization was defined as at least 1 HF readmission occurring between 31 and 365 days after the index procedure. Patients were classified according to the presence or absence of HF hospitalization during this period. Cox proportional hazards models were used to evaluate the association with mortality after adjustment for clinical, procedural, and sociodemographic factors.

resultsAmong 233 309 patients undergoing TAVR, 45 502 (19.5%) experienced HF hospitalization within 1 year. Patients with early HF hospitalization had markedly higher mortality compared with those without HF hospitalization, including 1-year mortality (43.8% versus 3.6%) and 5-year mortality (80.6% versus 41.0%) (log-rank

conclusionsNearly 1 in 5 older adults undergoing TAVR experience early HF hospitalization, which is associated with markedly increased short- and long-term mortality.

Indexed as

Aortic Valve StenosisHeart FailureHospitalizationPostoperative ComplicationsTranscatheter Aortic Valve ReplacementAgedAged, 80 and overFemaleHumansIncidenceMalePatient ReadmissionPrognosisRetrospective StudiesRisk AssessmentRisk Factorscardiac damageclinical outcomesfrailtyheart failuresocial vulnerabilitytranscatheter aortic valve replacement

Identifiers

PMID42179245
PMCPMC13315346

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.